Evidence map›Paper›PMID 21145026›Full record

ArticleAcademic radiology2011

Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.

Ketan B Ghaghada, Cristian T Badea, Lohitash Karumbaiah, Nicole Fettig, Ravi V Bellamkonda, G A Johnson, Ananth Annapragada

Open access · greenAbstract read
In one paragraph

Article in Academic radiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. System for delivering microwave ablation to subcutaneous tumors in small-animals under high-field MRI thermometry guidance.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ketan B GhaghadaThe University of Texas Health Sciences Center at Houston, TX 77030, USA.
Cristian T Badea
Lohitash Karumbaiah
Nicole Fettig
Ravi V Bellamkonda
G A Johnson
Ananth Annapragada
Duke Medical Center · USGeorgia Institute of Technology · USThe University of Texas Health Science Center at Houston · USWashington University in St. Louis · US

Funding

X-RAY RESEARCH AND DEVELOPMENT WITH/WITHOUT LIVE ANIMALSP41RR005959 · NCRR · DUKE UNIVERSITY · PI DZAU, VICTOR J · 1990 to 2011
$16.0M
Small Animal Imaging Resource ProgramU24CA092656 · NCI · DUKE UNIVERSITY · PI JOHNSON, GEORGE ALLAN · 2007 to 2011
$2.2M
NANOBIOLOGY INSTITUTIONAL TRAINING GRANT(RMI)R90DK071504 · NIDDK · UNIVERSITY OF HOUSTON · PI PETTITT, BERNARD MONTGOMERY · 2004 to 2008
$1.3M
NCI NIH HHS U24 CA092656NCRR NIH HHS P41 RR005959NIDDK NIH HHS R90 DK071504NIDDK NIH HHS R90 DK71504
6 · The paper itself

Abstract

RATIONALE AND

objectivesNon-invasive longitudinal imaging of tumor vasculature could provide new insights into the development of solid tumors, facilitating efficient delivery of therapeutics. In this study, we report three-dimensional imaging and characterization of tumor vascular architecture using a nanoparticle contrast agent and high-resolution computed tomography (CT) imaging. MATERIALS AND

methodsFive Balb/c mice implanted with 4T1/Luc syngeneic breast tumors cells were used for the study. The nanoparticle contrast agent was systemically administered and longitudinal CT imaging was performed pre-contrast and at serial time points post-contrast, for up to 7 days for studying the characteristics of tumor-associated blood vessels. Gene expression of tumor angiogenic biomarkers was measured using quantitative real-time polymerase chain reaction.

resultsEarly-phase imaging demonstrated the presence of co-opted and newly developed tumor vessels. The co-opted vessels demonstrated wall-permeability and "leakiness" characteristics evident by an increase in extravascular nanoparticle-based signal enhancement visible well beyond the margins of tumor. Diameters of tumor-associated vessels were larger than the contralateral normal vessels. Delayed-phase imaging also demonstrated significant accumulation of nanoparticle contrast agent both within and in areas surrounding the tumor. A heterogeneous pattern of signal enhancement was observed both within and among individual tumors. Gene-expression profiling demonstrated significant variability in several angiogenic biomarkers both within and among individual tumors.

conclusionsThe nanoparticle contrast agent and high-resolution CT imaging facilitated visualization of co-opted and newly developed tumors vessels as well as imaging of nanoparticle accumulation within tumors. The use of this agent could provide novel insights into tumor vascular biology and could have implications on the monitoring of tumor status.

Indexed as

Contrast MediaNanoparticlesTumor MicroenvironmentAnimalsDisease Models, AnimalFemaleImaging, Three-DimensionalMammary Neoplasms, ExperimentalMiceMice, Inbred BALB CRadiographic Image EnhancementReverse Transcriptase Polymerase Chain ReactionTomography, X-Ray ComputedTriiodobenzoic AcidsContrast MediaiodixanolTriiodobenzoic Acids

Identifiers

PMID21145026
PMCPMC3016875
OpenAlexW2134771619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.